Nexplanon bleeding can range from occasional spotting to frequent or prolonged episodes—or no bleeding at all. These changes are a known effect of the etonogestrel implant and do not, by themselves, mean it has stopped working. If bleeding bothers you, you can ask about an assessment and short-term treatment, or choose removal; you do not have to keep the implant.
What Nexplanon Bleeding Can Look Like
With the implant, bleeding may be irregular and hard to predict. Some people have light spotting, some have longer or more frequent bleeding, and others stop bleeding altogether. Heavy bleeding can happen, though it is less typical than irregular or light bleeding. Brown discharge can be spotting too; its colour alone does not show what is causing it.
There is no dependable calendar pattern to expect, and bleeding can change after you have used the implant for a while. Bleeding that starts after a year or two does not automatically mean the implant has failed or reached the end of its useful life. Note when it happens, how long it lasts and how heavy it is. That record can help you and a clinician decide whether to investigate or try treatment.
When to Check for Another Cause
It is reasonable to consider the implant as a cause, but not every episode of vaginal bleeding is due to contraception. A clinician may check for pregnancy, a sexually transmitted infection, thyroid problems, medication interactions or a condition affecting the uterus, depending on your symptoms and history. Bleeding after sex, a new pattern after a long stable period, or bleeding with pain deserves particular attention rather than an automatic assumption that the implant is responsible.
Seek prompt medical care if bleeding is very heavy and you feel faint or weak, or if you have severe pain. A clinician can also help assess persistent or distressing bleeding, even when it is not an emergency.
Short-Term Treatments That May Help
If you want to keep the implant, a clinician may offer a short course of treatment. Options in U.S. guidance include an anti-inflammatory medicine (an NSAID), an estrogen-containing pill or other estrogen treatment, tranexamic acid, or tamoxifen. Which option is suitable depends on your health, medicines and preferences. For example, estrogen-containing treatment is not appropriate for everyone, and you should not start a prescription medicine on your own.
These treatments aim to control an episode, not guarantee a lasting change in your bleeding pattern. Bleeding may return after treatment ends, particularly with estrogen-containing treatment or tranexamic acid. An NSAID or tamoxifen may have an effect that lasts beyond the course, but that does not mean the result is predictable for each person. Your clinician can explain the likely trade-offs and whether a particular option is appropriate for you.
The evidence does not point to one best treatment for everyone. In a 2025 study, Arianna Siconolfi and colleagues surveyed 141 gynaecologists in Italy about how they treat troublesome bleeding with the etonogestrel implant and reviewed treatment studies. Their survey found varied approaches, with up to 19% of respondents unsure what to do in some scenarios. The authors called for larger randomised trials with longer follow-up. This helps explain why treatment choices can differ between clinicians and countries. The U.S. Centers for Disease Control and Prevention’s 2024 guidance offers options for U.S. practice, but local guidance and access to medicines may vary elsewhere.
Removal Is an Option, Too
If bleeding is unacceptable to you, you can ask to have the implant removed. You do not have to try medication first or wait for a particular length of time. If avoiding pregnancy remains important, discuss another method and when to start it with your clinician so you can plan the transition.
Your preferences matter: treatment is optional, and continuing the implant is not the only reasonable choice. If you are unsure whether your bleeding needs investigation or which treatment fits your health history, arrange a conversation with a clinician.